IgE Allergy Blood Tests Market Size

IgE Allergy Blood Tests Market size is estimated to cross USD 53 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of IgE allergy blood tests was about USD 31 Billion. The major factor influencing the market expansion is the rising prevalence of asthma. With a projected 262.41 million prevalent cases (95% UI 224.05 to 309.45) worldwide, the burden of asthma has continued to climb. Hence, the demand for IgE allergy blood tests is growing. Asthma sufferers undergoing allergy testing typically have their IgE levels checked for airborne allergens that are known to frequently impact their symptoms.

Additionally, there has been growing awareness regarding the prevalence of allergies all across the globe by the government. They are launching various campaigns where they are offering free testing for allergies. This is why, the IgE allergy blood tests market is observing the growth in its revenue.

Frequently Asked Questions (FAQ)

The major factors driving the growth of the market are a surge in pollution levels, growing utilization of mHealth, and rising prevalence of food allergies.

The market size of IgE allergy blood tests is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market are Thermo Fisher Scientific, Inc., Eurofins Viracor, Neogen Corporation, Omega Diagnostics PLC and others.

The diagnostics laboratories segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

IgE Allergy Blood Tests Market Size